**Core Concept**
Medullary carcinoma of the thyroid is a type of neuroendocrine tumor that originates from the parafollicular cells (also known as C-cells) of the thyroid gland. The expression of specific oncogenes can contribute to the development and progression of this malignancy.

**Why the Correct Answer is Right**
The RET proto-oncogene is a receptor tyrosine kinase that plays a critical role in the development and differentiation of the thyroid gland. Mutations in the RET gene, particularly in the extracellular domain, can lead to the constitutive activation of the receptor, resulting in the uncontrolled growth and division of thyroid cells. This is a well-established risk factor for medullary thyroid carcinoma (MTC), particularly in families with a history of the disease. In fact, germline mutations in the RET gene are responsible for the majority of cases of familial MTC.

**Why Each Wrong Option is Incorrect**
**Option A:** The p53 gene is a tumor suppressor gene that plays a crucial role in preventing cancer by regulating cell growth and preventing DNA damage. Mutations in p53 are associated with a variety of cancers, including breast, colon, and lung cancer, but not specifically with medullary thyroid carcinoma.

**Option B:** The Her2/neu gene is a receptor tyrosine kinase that is overexpressed in some breast cancers, leading to the uncontrolled growth and division of cancer cells. While Her2/neu is an important target for cancer therapy, it is not directly associated with the development of medullary thyroid carcinoma.

**Option D:** The Rb gene is a tumor suppressor gene that regulates cell growth and division by inhibiting the cell cycle. Mutations in Rb are associated with retinoblastoma and other cancers, but not specifically with medullary thyroid carcinoma.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that medullary thyroid carcinoma is often associated with multiple endocrine neoplasia type 2 (MEN 2) syndrome, a rare genetic disorder that affects the parathyroid glands, adrenal glands, and thyroid gland. Patients with MEN 2 syndrome are at increased risk of developing MTC and should be screened regularly for this malignancy.

**✓ Correct Answer: C. RET proto oncogene**